Onko BCG 100

Onko BCG 100
Product Description

The product is intended for treatment of superficial, epithelial non-invasive urothelial carcinomas (carcinoma urotheliale Ta, Tis, T1)

„BIOMED-LUBLIN” S.A.

  • PL
  • 2021
    On CPhI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator
Specifications

„BIOMED-LUBLIN” S.A.

  • PL
  • 2021
    On CPhI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator

More Products from „BIOMED-LUBLIN” S.A.

  • Onko BCG 50

    Product Onko BCG 50

    The product is intended for treatment of superficial, epithelial non-invasive urothelial carcinomas (carcinoma urotheliale Ta, Tis, T1)

  • BCG 10 anti-tuberculosis vaccine

    Product BCG 10 anti-tuberculosis vaccine

    BCG 10 Anti-Tuberculosis Vaccine is used for protective vaccinations against tuberculosis.